Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Andrew W Bergen

Biographic Data

ID5210208
NAMEAndrew W Bergen
GIVEN NAMESAndrew W
FAMILY NAMEBergen
SIGNATUREBERGEN A W
AFFILIATIONSOregon Research Institute
ORCID0000-0002-1237-7644
VERIFIEDYes
TOTAL WORKS7
TOTAL CITATIONS2
WORKS AS AUTHOR7
WORKS AS EDITOR0
FIRST PUBLICATION YEAR1999
LATEST PUBLICATION YEAR2025
H-INDEX1
  • Community health survey development, administration, social determinants and mental health in African immigrants and refugees in Portland Oregon

    Open Access•Vincent Chirimwami, Egide Dukuzumuremyi et al.•ARTICLE•BMC Public Health•2025

    Survey development and administration in multiple languages benefited from validated tools, repeated consultations of the research team with Advisory Board members, and community-based organization staff contributions. Community concerns about mental health appear justified, though increased symptoms were mild and subclinical. While absolute levels of ever smoking are low, tobacco use associations suggest opportunities for prevention

  • Assessing Opioid Use Disorder Treatments in Trials Subject to Non-Adherence via a Functional Generalized Linear Mixed-Effects Model

    Open Access•Madeleine St Ville, Andrew W Bergen et al.•ARTICLE•International Journal of…•2022

    The opioid crisis in the United States poses a major threat to public health due to psychiatric and infectious disease comorbidities and death due to opioid use disorder (OUD). OUD is characterized by patterns of opioid misuse leading to persistent heavy use and overdose. The standard of care for treatment of OUD is medication-assisted treatment, in combination with behavioral therapy. Medications for opioid use disorder have been shown to improv…

  • Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials

    Open Access•Andrew W Bergen, James W Baurley et al.•ARTICLE•International Journal of…•2022

    The impact of agonist dose and of physician, staff and patient engagement on treatment have not been evaluated together in an analysis of treatment for opioid use disorder. Our hypotheses were that greater agonist dose and therapeutic engagement would be associated with reduced illicit opiate use in a time-dependent manner. Publicly-available treatment data from six buprenorphine efficacy and safety trials from the Federally-supported Clinical Tr…

  • Total Exposure Study Analysis consortium

    Open Access•Andrew W Bergen, Ruth E Krasnow et al.•ARTICLE•BMC Public Health•2015

    The Total Exposure Study was a stratified, multi-center, cross-sectional study designed to estimate levels of biomarkers of tobacco-specific and non-specific exposure and of potential harm in U.S. adult current cigarette smokers (≥one manufactured cigarette per day over the last year) and tobacco product non-users (no smoking or use of any nicotine containing products over the last 5 years). The study was designed and sponsored by a tobacco compa…

  • Environment And Genetics in Lung cancer Etiology (Eagle) study

    Open Access•Maria Teresa Landi, Dario Consonni et al.•ARTICLE•BMC Public Health•2008

    EAGLE is a new population-based case-control study that explores the full spectrum of lung cancer etiology, from smoking addiction to lung cancer outcome, through examination of epidemiological, molecular, and clinical data. We have provided a detailed description of the study design, field activities, management, and opportunities for research following this integrative approach, which allows a sharper and more comprehensive vision of the comple…

  • Predictors of Sustained Smoking Cessation

    Erik Augustson, Erik M Augustson et al.•ARTICLE•American Journal of Public Health•2008•Cited by: 2•References: 33

    Objectives. Because US smoking rates have not declined during the past decade, there is a renewed need to identify factors associated with smoking cessation. Using a nested case–control design, we explored the association between ability to sustain cessation over an extended period and demographic, smoking, medical, and behavioral variables. Methods. We selected a sample of 1379 sustained quitters (abstinent from smoking for at least 40 months) a…

  • Autosomal, mitochondrial, and Y chromosome DNA variation in Finland

    Open Access•Rick A Kittles, Andrew W Bergen et al.•ARTICLE•American Journal of Physical…•1999•References: 50

    The high prevalence of rare genetic diseases in Finland has been attributed to a founder effect some 2,000 years ago. However, this hypothesis has not been supported from mtDNA sequence and autosomal microsatellite data which indicate high levels of gene diversity. Here we have identified genetic evidence for a population bottleneck by examining variable microsatellite loci on the nonrecombining portion of Y chromosomes from Finland and four popu…

  • Predictors of Sustained Smoking Cessation

    Erik Augustson, Erik M Augustson et al.•ARTICLE•American Journal of Public Health•2008•Cited by: 2•References: 33

    Objectives. Because US smoking rates have not declined during the past decade, there is a renewed need to identify factors associated with smoking cessation. Using a nested case–control design, we explored the association between ability to sustain cessation over an extended period and demographic, smoking, medical, and behavioral variables. Methods. We selected a sample of 1379 sustained quitters (abstinent from smoking for at least 40 months) a…

  • Autosomal, mitochondrial, and Y chromosome DNA variation in Finland

    Open Access•Rick A Kittles, Andrew W Bergen et al.•ARTICLE•American Journal of Physical…•1999•References: 50

    The high prevalence of rare genetic diseases in Finland has been attributed to a founder effect some 2,000 years ago. However, this hypothesis has not been supported from mtDNA sequence and autosomal microsatellite data which indicate high levels of gene diversity. Here we have identified genetic evidence for a population bottleneck by examining variable microsatellite loci on the nonrecombining portion of Y chromosomes from Finland and four popu…

  • Environment And Genetics in Lung cancer Etiology (Eagle) study

    Open Access•Maria Teresa Landi, Dario Consonni et al.•ARTICLE•BMC Public Health•2008

    EAGLE is a new population-based case-control study that explores the full spectrum of lung cancer etiology, from smoking addiction to lung cancer outcome, through examination of epidemiological, molecular, and clinical data. We have provided a detailed description of the study design, field activities, management, and opportunities for research following this integrative approach, which allows a sharper and more comprehensive vision of the comple…

  • Predictors of Sustained Smoking Cessation

    Erik Augustson, Erik M Augustson et al.•ARTICLE•American Journal of Public Health•2008•Cited by: 2•References: 33

    Objectives. Because US smoking rates have not declined during the past decade, there is a renewed need to identify factors associated with smoking cessation. Using a nested case–control design, we explored the association between ability to sustain cessation over an extended period and demographic, smoking, medical, and behavioral variables. Methods. We selected a sample of 1379 sustained quitters (abstinent from smoking for at least 40 months) a…

  • Total Exposure Study Analysis consortium

    Open Access•Andrew W Bergen, Ruth E Krasnow et al.•ARTICLE•BMC Public Health•2015

    The Total Exposure Study was a stratified, multi-center, cross-sectional study designed to estimate levels of biomarkers of tobacco-specific and non-specific exposure and of potential harm in U.S. adult current cigarette smokers (≥one manufactured cigarette per day over the last year) and tobacco product non-users (no smoking or use of any nicotine containing products over the last 5 years). The study was designed and sponsored by a tobacco compa…

  • Assessing Opioid Use Disorder Treatments in Trials Subject to Non-Adherence via a Functional Generalized Linear Mixed-Effects Model

    Open Access•Madeleine St Ville, Andrew W Bergen et al.•ARTICLE•International Journal of…•2022

    The opioid crisis in the United States poses a major threat to public health due to psychiatric and infectious disease comorbidities and death due to opioid use disorder (OUD). OUD is characterized by patterns of opioid misuse leading to persistent heavy use and overdose. The standard of care for treatment of OUD is medication-assisted treatment, in combination with behavioral therapy. Medications for opioid use disorder have been shown to improv…

  • Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials

    Open Access•Andrew W Bergen, James W Baurley et al.•ARTICLE•International Journal of…•2022

    The impact of agonist dose and of physician, staff and patient engagement on treatment have not been evaluated together in an analysis of treatment for opioid use disorder. Our hypotheses were that greater agonist dose and therapeutic engagement would be associated with reduced illicit opiate use in a time-dependent manner. Publicly-available treatment data from six buprenorphine efficacy and safety trials from the Federally-supported Clinical Tr…

  • Community health survey development, administration, social determinants and mental health in African immigrants and refugees in Portland Oregon

    Open Access•Vincent Chirimwami, Egide Dukuzumuremyi et al.•ARTICLE•BMC Public Health•2025

    Survey development and administration in multiple languages benefited from validated tools, repeated consultations of the research team with Advisory Board members, and community-based organization staff contributions. Community concerns about mental health appear justified, though increased symptoms were mild and subclinical. While absolute levels of ever smoking are low, tobacco use associations suggest opportunities for prevention

Internal Medicine (5 works) · Medicine (5 works) · Biostatistics (3 works) · Environmental health (3 works) · Pathology (3 works) · Public health (3 works) · Buprenorphine (2 works) · Cancer (2 works) · Epidemiology (2 works) · Opioid (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae